|
|
|
| home > ebr > winter 2003 > technical and commercial due diligence in biotech transactions: doing the right things and doing them right |
|
|
 PUBLICATIONS |
European Biopharmaceutical Review
|
| This article argues that conducting due diligence properly to ensure that potential risks and opportunities in biotechnology transactions are fully understood is more important than ever as M&A and technology licensing activities accelerate. There are many ways to go about conducting due diligence, and the factors that determine the right way to proceed are discussed, with the pros and cons set out for taking an in-house approach, versus hiring external consultants. Whatever approach is taken, a due diligence plan is vital, given the often short timescales in which deals need to be closed. Keys to success are ensuring that an independent view is taken and that the right questions are asked, such that the answers truly help to support the investment decision. Due diligence can be an intensive and time-consuming process so the task should not be underestimated or left to the last minute - while it has costs in terms of time or professional fees, cutting corners can turn out to be far more costly. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
BIO-Europe Spring® 2012 — 6th International Partnering Conference
19-21 March 2012, Amsterdam RAI Convention Center, Amsterdam, The Netherlands
BIO-Europe Spring is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups.
More info >> |
|
 |
News and Press Releases |
 |
Pantec Biosolutions Showcases P.L.E.A.S.E.® Professional at the IMCAS Annual Congress
Pantec Biosolutions AG, the developer and manufacturer of P.L.E.A.S.E.® Professional, a state of the art portable laser device that sets new standards for safety, precision and versatility, today announced that it will present its recently launched P.L.E.A.S.E.® Professional laser device at the International Master Course on Aging Skin (IMCAS) from 26th-29th January 2012 in Paris, France.
More info >> |
|
|
